Patent application number | Description | Published |
20120042416 | Antibody fusion-mediated plant resistance against Oomycota - The present invention relates to fusion proteins comprising anti-Oomycotic proteins or peptides linked to an antibody or fragment thereof specifically recognising an epitope of an Oomycota. The invention is also directed to polynucleotides coding for the fusion proteins. The embodiments of the present invention are particularly useful for the protection of plants against Oomycota. The invention therefore comprises transgenic plants expressing the fusion proteins of the present invention. | 02-16-2012 |
20140053300 | METHOD FOR THE GENERATION OF A MONOCLONAL PLANT CELL LINE - The invention provides a method for the generation of a monoclonal plant cell line from a heterologous population of plant cells, comprising the following steps: (a) provision of a heterologous population of plant cells; (b) preparation of protoplasts from said heterologous population of plant cells; (c) separation of single protoplasts by subjecting the preparation of protoplasts to flow cytometric sorting; (d) regeneration of a separated single transformed protoplast until the formation of a microcolony by co-cultivation in the presence of feeder cell material; (e) removal of the microcolony from the feeder cell material and cultivation of the microcolony until the formation of a monoclonal plant cell line. | 02-20-2014 |
20140303060 | PROCESS FOR DEGRADING A BIOFILM ON SURFACES OF OBJECTS - A process for degrading a biofilm on surfaces of objects by means of an extract of a bacterium of the genus | 10-09-2014 |
20150148415 | DERIVATIZED DENDRIMER WITH LOW CITOTOXICITY FOR IN VIVO, EX VIVO, IN VITRO OR IN SITU CHELATION OF HEAVY METALS OR ACTINIDES - The present invention considers derivatized nanomolecules with proven effectiveness to bind to actinides, more specifically uranium, during in vivo, ex vivo, in vitro or in situ assays. When assayed in vivo, the invention showed a reduction in at least kidney damage due to exposition to uranium. | 05-28-2015 |
20150191518 | NOVEL MALARIA TRANSMISSION-BLOCKING VACCINES - Immunogenic compositions, vaccines, constructions, host cells, and vectors that include or express one or more PfGAP50 antigen or fragment thereof. The vaccine may include an adjuvant, a pharmaceutically acceptable salt, an excipient, a preservative, a binder or a pharmaceutically acceptable liquid. | 07-09-2015 |
20150197562 | NOVEL ANTI-PLASMODIUM PARASITE ANTIBODIES - The technology provided herein relates to novel human antibodies against | 07-16-2015 |
20150218232 | ARTIFICIAL FORISOME BODY WITH SEO-F FUSION PROTEINS, PLANT OR YEAST CELLS COMPRISING VECTORS WHICH CODE FOR THESE PROTEINS, AS WELL AS VECTORS WHICH CODE FOR SEO-F FUSION PROTEINS - The invention relates to artificial forisome bodies comprising a fusion protein of at least one SEO-F protein or an at least 50-amino acid portion thereof, and at least one additional protein or peptide, with the exception of GFP and the Venus protein, wherein
| 08-06-2015 |
20150353945 | NUCLEIC ACID SEQUENCES AND PEPTIDES/PROTEINS OF THE FT FAMILY PROVIDING FLOWER REPRESSING PROPERTIES IN TOBACCO AND TRANSGENIC PLANTS TRANSFORMED THEREWITH - The present invention is directed to nucleic acid sequences coding for a protein which, (1) under a respective promoter, is able to suppress or repress or delay flowering of a plant, and (2) includes the motive “NAPDIIDS” (SEQ ID NO: 10) or, in preferred cases, “VNAPDIIDS” SEQ ID NO: 67), with the exception of the nucleic acid of the gene StSP5G or a part thereof. Preferably, the nucleic acid sequence belongs phylogenetically to the FT-clade of the PEBP gene family, wherein the motive “(V)NAPDIIDS” (SEQ ID NO: 68) is in place of the “(V)YAPGW” motive_ (SEQ ID NO: 69) of the flowering promoting proteins AtFT and BvFT2. | 12-10-2015 |